Clinical Trial Update: Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing rituximab to mycophenolate mofetil in children with refractory nephrotic syndrome was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frequent Relapsing Nephrotic Syndrome
• Nephrotic Syndrome
• Steroid-dependent Nephrotic Syndrome

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Rituximab (rituximab)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Frequent Relapsing Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2019-03-26